OMALIZUMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where OMALIZUMAB was used for Prostate cancer.
Most Reported Side Effects for OMALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 9,736 | 15.3% | 0 | 3 |
| Asthma | 9,354 | 14.7% | 208 | 4,275 |
| Urticaria | 9,231 | 14.5% | 39 | 1,723 |
| Off label use | 9,199 | 14.4% | 100 | 627 |
| Dyspnoea | 8,323 | 13.0% | 133 | 3,674 |
| Drug ineffective | 6,747 | 10.6% | 57 | 1,465 |
| Cough | 5,926 | 9.3% | 86 | 2,751 |
| Pruritus | 5,224 | 8.2% | 32 | 1,202 |
| Fatigue | 5,053 | 7.9% | 94 | 1,826 |
| Malaise | 4,820 | 7.6% | 113 | 2,032 |
| Wheezing | 4,522 | 7.1% | 78 | 2,000 |
| Headache | 4,416 | 6.9% | 47 | 1,505 |
| Pneumonia | 4,251 | 6.7% | 133 | 2,318 |
| Pain | 3,605 | 5.7% | 46 | 1,198 |
| Nasopharyngitis | 3,421 | 5.4% | 48 | 1,472 |
Other Indications for OMALIZUMAB
Asthma (24,041)
Product used for unknown indication (14,050)
Chronic spontaneous urticaria (9,063)
Idiopathic urticaria (8,366)
Urticaria (5,500)
Urticaria chronic (1,064)
Food allergy (624)
Angioedema (412)
Hypersensitivity (364)
Rhinitis allergic (305)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)